Clinical trial
Comparison of Angiogenic Factors in the Placentas of Parturient Women With COVID-19
NCT06644521 is registered in ClinicalTrials.gov with Manisa Celal Bayar University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of Angiogenic Factors in the Placentas of Parturient Women With COVID-19
- Lead sponsor
- Manisa Celal Bayar University
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 1, 2020
- Completion date
- April 17, 2023
- Enrollment
- 40 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
angiogenesis, covid-19, placenta diseases